AWM
TEVA icon

Ameliora Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ameliora Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Sell
700
-300
-30% -$9.99K 0.01% 173
2026
Q1 		$30.1K Sell
1,000
-2,000
-67% -$64.3K 0.01% 168
2025
Q4 		$93.6K Hold
3,000
– – 0.03% 133
2025
Q3 		$60.6K Hold
3,000
– – 0.02% 143
2025
Q2 		$50.3K Hold
3,000
– – 0.02% 150
2025
Q1 		$46.1K Hold
3,000
– – 0.02% 158
2024
Q4 		$66.1K Buy
+3,000
New +$54.6K 0.02% 147

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Ameliora Wealth Management's TEVA Position: Q2 2026 in Review

Ameliora Wealth Management reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 30% in Q2 2026, selling an estimated $9.99K and leaving 700 shares worth $23.7K. The position accounts for 0.01% of the portfolio, ranked #173.

Ameliora Wealth Management first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $93.6K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Ameliora Wealth Management held 700 shares of Teva Pharmaceutical Industries Limited worth $23.7K as of Q2 2026.
  • Ameliora Wealth Management sold 300 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $9.99K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Ameliora Wealth Management's portfolio in Q2 2026, its #173 holding.
  • Ameliora Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2024 and has held it in 7 quarters since.
  • Ameliora Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $93.6K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Ameliora Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.